Agios Pharmaceuticals, Inc.
AGIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,334 | $1,927 | $1,684 | $1,878 |
| - Cash | $93 | $81 | $79 | $76 |
| + Debt | $45 | $49 | $53 | $57 |
| Enterprise Value | $2,286 | $1,895 | $1,658 | $1,859 |
| Revenue | $13 | $12 | $9 | $11 |
| % Growth | 3.4% | 42.7% | -18.7% | – |
| Gross Profit | $11 | $9 | $8 | $9 |
| % Margin | 87% | 76.2% | 87.6% | 88.3% |
| EBITDA | -$102 | -$111 | -$105 | -$124 |
| % Margin | -792.4% | -889.3% | -1,207.3% | -1,152.6% |
| Net Income | -$103 | -$112 | -$89 | -$97 |
| % Margin | -803.1% | -899.4% | -1,023.3% | -899.6% |
| EPS Diluted | -1.78 | -1.93 | -1.55 | -1.69 |
| % Growth | 7.8% | -24.5% | 8.3% | – |
| Operating Cash Flow | -$88 | -$77 | -$111 | -$133 |
| Capital Expenditures | -$2 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$90 | -$78 | -$112 | -$134 |